Uncategorized FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades Last updated: September 26, 2024 11:23 pm Share 0 Min Read SHARE The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia. You Might Also Like Boeing freezes hiring in sweeping cost cuts as it grapples with factory worker strike NWSL eliminates draft, grants unrestricted free agency to players Best Buy raises full-year profit guidance after earnings and revenue beat A look at the behind-the-scenes business of Hollywood studio lot tours Ford delays new EV plant, cancels electric three-row SUV Sign Up For Daily NewsletterBe keep up! Get the latest breaking news delivered straight to your inbox.[mc4wp_form]By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time. Share This Article Facebook Twitter Copy Link Print Share Previous Article Trademark dispute emerges over Tiger Woods’ new logo Next Article Why JPMorgan Chase is prepared to sue the U.S. government over Zelle scams Leave a comment Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay Connected235.3kFollowersLike69.1kFollowersFollow11.6kFollowersPin56.4kFollowersFollow136kSubscribersSubscribe4.4kFollowersFollow - Advertisement - Latest News GM ditching ‘Ultium’ name for batteries, tech amid EV changes Uncategorized October 8, 2024 Boeing delivers 33 jets in September but strike impact looms Uncategorized October 8, 2024 Airlines, theme parks, cruise lines warn travelers about Hurricane Milton disruptions Uncategorized October 8, 2024 Walmart opens five more veterinary and grooming centers, as it makes bigger push in pets Uncategorized October 8, 2024
